Royalty Report: Drugs, Biotechnology, Diagnostic – Collection: 26590

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Drugs
  • Biotechnology
  • Diagnostic
  • Diagnostic Substances
  • Cancer
  • Medical
  • Device
  • Test/Monitoring

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26590

License Grant
The Company entered into worldwide, non-exclusive polymerase chain reaction (PCR) license agreements. One agreement grants the Company rights to make, import, use and sell certain PCR products within specified fields, while the other agreement grants the Company rights to perform certain PCR services within specified fields.

IPSCIO Record ID: 27595

License Grant
The Company obtained a non-exclusive license to manufacture and sell products which are useful in polymerase chain reaction (PCR) process and which enable the user to perform in vitro parentage determination testing procedures.
License Property
The licensed product is a reagent kit manufactured by Licensee containing a thermostable DNA polymerase in combination with all such other reagents, enzymes or materials, whether packaged together or separately, as are necessary to perform a PCR-based assay for Parentage Determination Testing, which is covered by at least one Valid Claim within PCR Technology, and (a) which is marketed for use in Parentage Determination Testing and (b) bears a label as specified in in the agreement, setting forth the license limitations.  Licensor owns and has the right to grant licenses under the corresponding foreign counterpart patents and patent applications describing and claiming nucleic acid amplification techniques, including inter alia, a process known as the PCR process.

IPSCIO Record ID: 2099

License Grant
The Company hereby grants a non-exclusive immunity from suit under PCR Technology solely to use Licensed Technology to perform Licensed Services within the United States and its possessions and the Commonwealth of Puerto Rico; gene amplification process known as the polymerase chain reaction ('PCR') technology (by United States Patent Nos. B1 4,683,195 and B1 4,683,202).
License Property
'Licensed Technology' shall mean the application of PCR Technology.

PCR Technology is used to detect the presence, absence or quantity of a nucleic acid sequence associated with a specific human disease or condition.

Field of Use
Licensed Field shall mean the field of human in vitro diagnostics solely for the detection of genetic diseases, genetic pre-disposition to disease, microorganisms associated with infectious diseases, cancer, or for tissue transplant typing or Parentage.

IPSCIO Record ID: 372579

License Grant
This amendment updates the amendment date, territory and royalties.  The original agreement in non-exclusive.
License Property
The original license is for Licensed Real-Time Thermal Cycler shall mean an instrument, whether sold as an integrated product or as one or more components or modules, the manufacture, importation, offer for sale, sale or use of which would, but for the rights granted under this Agreement, infringe at least one Valid Claim of the Real-Time Apparatus Patent Rights.

Real-time PCR thermal cyclers/thermocyclers carry out quantitative PCR (qPCR) for experiments in gene expression, genetic variation, genotyping, and specific detection of rare targets, bacteria, and viruses.

Field of Use
The Fields shall mean research, and all applied fields, specifically including food testing. The term Fields does not include the Human In Vitro Diagnostic Field or veterinary in vitro diagnostic applications.

Product relates to Polymerase Chain Reaction (PCR) and instruments (thermal cycler) for performing PCR.
Polymerase chain reaction is a method widely used to rapidly make millions to billions of copies of a specific DNA sample, allowing scientists to take a very small sample of DNA and amplify it to a large enough amount to study in detail.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.